Literature DB >> 9347128

Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls.

A D Radant1, K Claypoole, D K Wingerson, D S Cowley, P P Roy-Byrne.   

Abstract

Establishing the relationship between oculomotor and neuropsychological impairments might facilitate a more coherent description of schizophrenia-associated neurocognitive deficits. Therefore, we assessed several aspects of neuropsychological and oculomotor function in 25 medicated schizophrenia patients and 24 age-matched controls. Neuropsychological tasks included the Wisconsin Cart Sort Test (WCST), the Trail Making Test (TMT), the Rey Auditory Verbal Learning Test, and finger tapping speed. Oculomotor functions assessed included smooth pursuit, initiation of smooth pursuit, predictive pursuit, fixation, visually guided saccades, remembered saccades, and antisaccades. Among the schizophrenia patients, predictive pursuit performance correlated significantly with finger tapping (dominant hand), TMT (both parts), and one WCST measure (categories completed). The only other significant correlation among the schizophrenia patients was between antisaccade performance and part A of the TMT. Perseverative errors during the WCST and antisaccade performance were the only measures significantly correlated among the normals. Closely related neurocognitive deficits may be responsible for impairments in TMT, WCST, predictive pursuit, and antisaccade performance in schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9347128     DOI: 10.1016/s0006-3223(96)00464-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Smooth pursuit and saccadic eye movement performance in a prefrontal leukotomy patient.

Authors:  D C Gooding; W G Iacono; D R Hanson
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations.

Authors:  Deborah L Levy; Nancy R Mendell; Philip S Holzman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

3.  Multicenter validation of a bedside antisaccade task as a measure of executive function.

Authors:  J Hellmuth; J Mirsky; H W Heuer; A Matlin; A Jafari; S Garbutt; M Widmeyer; A Berhel; L Sinha; B L Miller; J H Kramer; A L Boxer
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

4.  Advances in endophenotyping schizophrenia.

Authors:  David L Braff; Tiffany A Greenwood; Neal R Swerdlow; Gregory A Light; Nicholas J Schork
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 5.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 6.  Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Authors:  Kristen J Brennand; Melissa A Landek-Salgado; Akira Sawa
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

7.  Oculomotor inhibitory control in express saccade makers.

Authors:  Felicity D A Wolohan; Paul C Knox
Journal:  Exp Brain Res       Date:  2014-09-03       Impact factor: 1.972

Review 8.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

9.  Is motion perception deficit in schizophrenia a consequence of eye-tracking abnormality?

Authors:  L Elliot Hong; Kathleen A Turano; Hugh B O'Neill; Lei Hao; Ikwunga Wonodi; Robert P McMahon; Gunvant K Thaker
Journal:  Biol Psychiatry       Date:  2008-12-03       Impact factor: 13.382

10.  The impact of oculomotor functioning on neuropsychological performance in Huntington disease.

Authors:  Janessa O Carvalho; Jeffrey D Long; Holly J Westervelt; Megan M Smith; Jared M Bruce; Ji-In Kim; James A Mills; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2016       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.